Cartesian Therapeutics said new Phase 2 retreatment data for Descartes-08 in myasthenia gravis supports its ongoing Phase 3 AURORA trial. The findings were presented at the MGFA Scientific Session at AANEM in Orlando.
published
Cartesian Therapeutics said new Phase 2 retreatment data for Descartes-08 in myasthenia gravis supports its ongoing Phase 3 AURORA trial. The findings were presented at the MGFA Scientific Session at AANEM in Orlando.
Latest documented BWB result
See Billy's timestamped results and follow-through.
Review the latest gains posts, original timestamps, and proof images published by Banking With Billy.
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.